152 related articles for article (PubMed ID: 23665090)
1. Kinetics and mechanism of reactions of the drug tiopronin with platinum(IV) complexes.
Huo S; Shi H; Liu D; Shen S; Zhang J; Song C; Shi T
J Inorg Biochem; 2013 Aug; 125():9-15. PubMed ID: 23665090
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of 3,6-dioxa-1,8-octanedithiol by platinum(IV) anticancer prodrug and model complex: kinetic and mechanistic studies.
Huo S; Shen S; Liu D; Shi T
J Phys Chem B; 2012 Jun; 116(22):6522-8. PubMed ID: 22574871
[TBL] [Abstract][Full Text] [Related]
3. L-selenomethionine reduces platinum(IV) anticancer model compounds at strikingly faster rates than L-methionine.
Huo S; Dong J; Shen S; Ren Y; Song C; Xu J; Shi T
Dalton Trans; 2014 Nov; 43(41):15328-36. PubMed ID: 25075569
[TBL] [Abstract][Full Text] [Related]
4. Kinetics and mechanism for reduction of the anticancer prodrug trans,trans,trans-[PtCl2(OH)2(c-C6H11NH2)(NH3)] (JM335) by thiols.
Lemma K; Shi T; Elding LI
Inorg Chem; 2000 Apr; 39(8):1728-34. PubMed ID: 12526561
[TBL] [Abstract][Full Text] [Related]
5. Reduction of ormaplatin and cis-diamminetetrachloroplatinum(iv) by ascorbic acid and dominant thiols in human plasma: kinetic and mechanistic analyses.
Dong J; Ren Y; Huo S; Shen S; Xu J; Tian H; Shi T
Dalton Trans; 2016 Jul; 45(28):11326-37. PubMed ID: 27327648
[TBL] [Abstract][Full Text] [Related]
6. Reduction of some Pt(IV) complexes with biologically important sulfur-donor ligands.
Jovanović S; Petrović B; Bugarčić ŽD; van Eldik R
Dalton Trans; 2013 Jun; 42(24):8890-6. PubMed ID: 23657491
[TBL] [Abstract][Full Text] [Related]
7. Importance of platinum(II)-assisted platinum(IV) substitution for the oxidation of guanosine derivatives by platinum(IV) complexes.
Choi S; Vastag L; Larrabee YC; Personick ML; Schaberg KB; Fowler BJ; Sandwick RK; Rawji G
Inorg Chem; 2008 Feb; 47(4):1352-60. PubMed ID: 18220340
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and mechanism for reduction of anticancer-active tetrachloroam(m)ine platinum(IV) compounds by glutathione.
Lemma K; Berglund J; Farrell N; Elding LI
J Biol Inorg Chem; 2000 Jun; 5(3):300-6. PubMed ID: 10907740
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insight into protonolysis and cis-trans isomerization of benzylplatinum(II) complexes assisted by weak ligand-to-metal interactions. A combined kinetic and DFT study.
Guido E; D'Amico G; Russo N; Sicilia E; Rizzato S; Albinati A; Romeo A; Plutino MR; Romeo R
Inorg Chem; 2011 Mar; 50(6):2224-39. PubMed ID: 21341750
[TBL] [Abstract][Full Text] [Related]
10. Spectroscopic, kinetic, and theoretical analyses of oxidation of dl-ethionine by Pt(IV) anticancer model compounds.
Wang J; Yao H; Lu T; Dong J; Xu B; Liu Y; Liu C; Zhou L; Shi T
Spectrochim Acta A Mol Biomol Spectrosc; 2019 Dec; 223():117328. PubMed ID: 31295632
[TBL] [Abstract][Full Text] [Related]
11. Reactivity of the glutathione species towards the reduction of ormaplatin (or tetraplatin).
Dong J; Huo S; Shen S; Xu J; Shi T; Elding LI
Bioorg Med Chem Lett; 2016 Sep; 26(17):4261-6. PubMed ID: 27481559
[TBL] [Abstract][Full Text] [Related]
12. Quantitative measurement of the reduction of platinum(IV) complexes using X-ray absorption near-edge spectroscopy (XANES).
Hall MD; Daly HL; Zhang JZ; Zhang M; Alderden RA; Pursche D; Foran GJ; Hambley TW
Metallomics; 2012 Jun; 4(6):568-75. PubMed ID: 22569908
[TBL] [Abstract][Full Text] [Related]
13. Thiolate bridging and metal exchange in adducts of a zinc finger model and Pt(II) complexes: biomimetic studies of protein/Pt/DNA interactions.
Almaraz E; de Paula QA; Liu Q; Reibenspies JH; Darensbourg MY; Farrell NP
J Am Chem Soc; 2008 May; 130(19):6272-80. PubMed ID: 18422317
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic elucidation of linker and ancillary ligand substitution reactions in Pt(II) dinuclear complexes.
Ongoma PO; Jaganyi D
Dalton Trans; 2013 Feb; 42(8):2724-34. PubMed ID: 23223554
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and mechanism of oxidation of the anti-tubercular prodrug isoniazid and its analog by iridium(iv) as models for biological redox systems.
Dong J; Ren Y; Sun S; Yang J; Nan C; Shi H; Xu J; Duan J; Shi T; Elding LI
Dalton Trans; 2017 Jul; 46(26):8377-8386. PubMed ID: 28621793
[TBL] [Abstract][Full Text] [Related]
16. Investigations of the Kinetics and Mechanism of Reduction of a Carboplatin Pt(IV) Prodrug by the Major Small-Molecule Reductants in Human Plasma.
Liu Y; Tian H; Xu L; Zhou L; Wang J; Xu B; Liu C; Elding LI; Shi T
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726728
[TBL] [Abstract][Full Text] [Related]
17. Dependence of the reduction products of platinum(IV) prodrugs upon the configuration of the substrate, bulk of the carrier ligands, and nature of the reducing agent.
Sinisi M; Intini FP; Natile G
Inorg Chem; 2012 Sep; 51(18):9694-704. PubMed ID: 22921246
[TBL] [Abstract][Full Text] [Related]
18. Oxidation of guanosine derivatives by a platinum(IV) complex: internal electron transfer through cyclization.
Choi S; Cooley RB; Voutchkova A; Leung CH; Vastag L; Knowles DE
J Am Chem Soc; 2005 Feb; 127(6):1773-81. PubMed ID: 15701012
[TBL] [Abstract][Full Text] [Related]
19. Mechanistic studies on the interaction of reduced cobalamin (vitamin B12r) with nitroprusside.
Wolak M; Stochel G; van Eldik R
J Am Chem Soc; 2003 Feb; 125(5):1334-51. PubMed ID: 12553836
[TBL] [Abstract][Full Text] [Related]
20. Kinetic and mechanistic study of the Pt(II) versus Pt(IV) effect in the platinum-mediated nitrile-hydroxylamine coupling.
Luzyanin KV; Kukushkin VY; Ryabov AD; Haukka M; Pombeiro AJ
Inorg Chem; 2005 Apr; 44(8):2944-53. PubMed ID: 15819582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
